The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target. - Test2 - elhamkhani - TriplyDB

The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.

The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.

http://www.wikidata.org/entity/Q39127472

about

Overexpression of erythropoietin-producing hepatocyte receptor B4 and ephrin-B2 is associated with estrogen receptor expression in endometrial adenocarcinoma.The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder Elevated serum levels of cysteine and tyrosine: early biomarkers in asymptomatic adults at increased risk of developing metabolic syndrome.Periostin: A Downstream Mediator of EphB4-Induced Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells.PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell Carcinomas.Eph receptors and ephrins: therapeutic opportunities.Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.KSR1 and EPHB4 Regulate Myc and PGC1β To Promote Survival of Human Colon Tumors.Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung Cancer Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.Anti-tumour effects of antibodies targeting the extracellular cysteine-rich region of the receptor tyrosine kinase EphB4.Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibition.Aberrant EPHB4 gene methylation and childhood acute lymphoblastic leukemia.Intersecting transcriptomic profiling technologies and long non-coding RNA function in lung adenocarcinoma: discovery, mechanisms, and therapeutic applications.EphB4 Regulates Self-Renewal, Proliferation and Neuronal Differentiation of Human Embryonic Neural Stem Cells in Vitro.EphB4: A promising target for upper aerodigestive malignancies.Clinical Significance of EphB4 and EphB6 Expression in Human Malignant and Benign Thyroid Lesions.Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers.Association of internal smoking dose with blood DNA methylation in three racial/ethnic populations

P2860

Q33599430-04DB00C1-37C8-420C-B936-0D9FFCED28FE Q34078717-E3D88150-2851-4A08-BC9A-704B0DFDF74D Q35189600-CF174E6D-A3E2-4C20-8AFB-89D63316DCF1 Q36415891-E665CE46-827B-4052-8B95-75898FBD4DAF Q37252398-00DD7E54-383D-4998-924E-1467A6DB66DB Q37493010-CA468689-BFE4-436B-A025-AB58D61D823D Q38257853-E66DB3C1-CC67-4889-AEC2-F9828516275B Q38694303-4528FB66-8366-4BBA-887B-1222D97F0F58 Q38765961-B67AA6E0-48CA-40A1-A897-9F7F240F0413 Q38864169-8C0F0FD8-2B75-43B5-B981-560B0A1FEA11 Q40482740-CC2202BA-1A58-4D9D-B8F6-AC98706596B2 Q41828383-35DD3190-DE1C-46B6-A5D2-9AFB515CDBFB Q43083986-80238F37-B653-45A6-B297-A29AF437F7A8 Q45355262-09E52C20-9457-496A-B1BD-B7B2088AF5D6 Q46077218-E641045C-4F18-4C45-A823-890D8489FCF3 Q48302674-544F49B0-4920-4DF2-84D2-5ACEF4544304 Q49709391-58336C38-5BD2-44E6-899A-5EF44E1705D6 Q53403455-767355ED-7F81-4680-8FCA-F85A8642985A Q55286883-60BE4CA4-1851-4164-9CFF-BEE5A41F2376 Q58713713-5400A2BE-DDA1-444B-BE09-4B6C4744F635

P2860

The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.

http://www.wikidata.org/entity/Q39127472

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

The EphB4 receptor tyrosine ki ...... tial novel therapeutic target.

@en

The EphB4 receptor tyrosine ki ...... tial novel therapeutic target.

@nl

type

label

The EphB4 receptor tyrosine ki ...... tial novel therapeutic target.

@en

The EphB4 receptor tyrosine ki ...... tial novel therapeutic target.

@nl

prefLabel

The EphB4 receptor tyrosine ki ...... tial novel therapeutic target.

@en

The EphB4 receptor tyrosine ki ...... tial novel therapeutic target.

@nl

P1433

Q39127472-7C073E14-90AB-4480-98EF-CD9585ED7B53

P1476

Q39127472-62B902A2-9A22-4394-B2BF-7DB2865A80DB

P2093

Q39127472-09B6BFFC-3B26-45A0-873C-53A1EF365E9A

Q39127472-42CB6866-888B-44AC-A5F4-7D1DE85F501E

Q39127472-46EAA294-F31B-411E-BB5F-E3C0158A20BE

Q39127472-47D01886-B677-40A4-A918-893F85122DBB

Q39127472-5F39EBD4-99D8-413B-8874-F9731E6B8593

Q39127472-60DFA95F-2CE5-46A8-BE01-E3317D6EE594

Q39127472-6E4FDF5B-9D22-4650-881B-F094CC86F897

Q39127472-79300F81-32C5-4EA0-B6FF-C9ED4203B451

Q39127472-7CD82CE4-B9D4-4BA1-ACFC-AD81AB0AB265

Q39127472-7E355BD8-3E33-40A2-9218-59C8E9342449

P2860

Q39127472-0047BD21-6D79-498E-B008-8D4C35BB42C0

Q39127472-01190197-7C43-42BE-BCEA-13126DC5B9D3

Q39127472-087AB825-66DA-4090-98D5-4225EB39A0B9

Q39127472-145499CC-38D0-4CF7-86C8-CC6F6A7549B9

Q39127472-1C3A58FE-5DF1-4D1D-9DB8-96F4825D4445

Q39127472-25229F4D-D466-4B28-B97E-FE13500FF60F

Q39127472-257D54C2-54F7-48B7-B645-B094FC9C8E6D

Q39127472-2B1618A5-51ED-46CF-83A3-F114C0CE8760

Q39127472-2B969330-66BF-4B9C-84C0-84990902484B

Q39127472-2C8C58DD-8879-4204-90B3-A6252B1F596D

P304

Q39127472-A6715579-08AC-472F-8415-560EF1C2E195

P31

Q39127472-63AEE95C-89EA-4D54-B951-E569B50ABA62

P356

Q39127472-ADE827E6-2F85-4249-8667-1E3865BB0267

P407

Q39127472-B20FD82E-C28D-4C73-8F01-C3D42D9CD764

P433

Q39127472-6A22B9A8-1E32-411E-BCB6-46F40CDC31A3

P478

Q39127472-B9F8A4ED-6D45-4B18-A056-9B47F9215A5E

P50

Q39127472-9A58A133-BE9A-4462-B1AF-2A149FBF3949

Q39127472-B717DCEA-63D9-461A-BBBA-56EE61E150AD

P577

Q39127472-E38F8F84-4A8F-4214-9643-5AD4D897D4E6

P5875

Q39127472-70B320E0-27D0-4DE8-899D-0AB037E43007

P698

Q39127472-E704E357-49CF-415E-89A4-C975E09FFCB6

P932

Q39127472-F66AC164-253B-4B2B-BDBB-F60EFF0843C4

P356

JOURNAL.PONE.0067668

P1433

P1476

The EphB4 receptor tyrosine ki ...... tial novel therapeutic target.

@en

P2093

A John Iafrate

http://www.w3.org/2001/XMLSchema#string

Aliya N Husain

http://www.w3.org/2001/XMLSchema#string

Benjamin D Ferguson

http://www.w3.org/2001/XMLSchema#string

Cleo E Rolle

http://www.w3.org/2001/XMLSchema#string

Gustavo M Cervantes

http://www.w3.org/2001/XMLSchema#string

Leonardo Faoro

http://www.w3.org/2001/XMLSchema#string

Maria S Tretiakova

http://www.w3.org/2001/XMLSchema#string

Mark K Ferguson

http://www.w3.org/2001/XMLSchema#string

Parkash S Gill

http://www.w3.org/2001/XMLSchema#string

Rajani Kanteti

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

Structural and biophysical characterization of the EphB4*ephrinB2 protein-protein interaction and receptor specificity

EphB4 expression and biological significance in prostate cancer

Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer

Investigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma.

Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines

Inhibitors of the tyrosine kinase EphB4. Part 2: structure-based discovery and optimisation of 3,5-bis substituted anilinopyrimidines

Inhibitors of the tyrosine kinase EphB4. Part 3: identification of non-benzodioxole-based kinase inhibitors

Inhibitors of the tyrosine kinase EphB4. Part 4: Discovery and optimization of a benzylic alcohol series

Cancer statistics, 2013

P304

e67668

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0067668

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Everett E Vokes

P577

2013-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

248398242

http://www.w3.org/2001/XMLSchema#string

P698

23844053

http://www.w3.org/2001/XMLSchema#string

P932

3699624

http://www.w3.org/2001/XMLSchema#string